1. Acteoside alleviates dextran sulphate sodium‑induced ulcerative colitis via regulation of the HO‑1/HMGB1 signaling pathway
- Author
-
Wenjuan, Guo, Xiaodi, Wang, Fang, Liu, Shuo, Chen, Shuai, Wang, Qingrui, Zhang, Lan, Yuan, and Shiyu, Du
- Subjects
Inflammation ,Cancer Research ,Caspase 3 ,Dextran Sulfate ,Anti-Inflammatory Agents ,Protoporphyrins ,Colitis ,Biochemistry ,Mice ,Oncology ,Tin ,Genetics ,Humans ,Animals ,Molecular Medicine ,Colitis, Ulcerative ,HMGB1 Protein ,Caco-2 Cells ,Molecular Biology ,Heme Oxygenase-1 ,bcl-2-Associated X Protein ,Signal Transduction - Abstract
Ulcerative colitis (UC) is a significant burden on human health, and the elucidation of the mechanism by which it develops has potential for the prevention and treatment of UC. It has been reported that acteoside (ACT) exhibits strong anti‑inflammatory activity. In the present study, it was hypothesized that ACT may exert a protective effect against UC. The effects of ACT on inflammation, oxidative stress and apoptosis were evaluated using dextran sulphate sodium (DSS)‑treated mice and DSS‑treated human colorectal adenocarcinoma Caco‑2 cells, which have an epithelial morphology. The results demonstrated that the ACT‑treated mice with DSS‑induced UC exhibited significantly reduced colon inflammation, as demonstrated by a reversal in body weight loss, colon shortening, disease activity index score, inflammation, oxidative stress and colonic barrier dysfunction. Further
- Published
- 2022